US 11,684,415 B2
Tissue ablation and monitoring thereof
Amr Salahieh, Saratoga, CA (US); John P. Claude, Redwood City, CA (US); and Tom Saul, El Granada, CA (US)
Assigned to Boston Scientific Scimed, Inc., Maple Grove, MN (US)
Filed by Boston Scientific Scimed, Inc., Maple Grove, MN (US)
Filed on Oct. 11, 2018, as Appl. No. 16/157,940.
Application 16/157,940 is a continuation of application No. 14/749,507, filed on Jun. 24, 2015, granted, now 10,098,694.
Application 14/749,507 is a continuation in part of application No. 14/248,288, filed on Apr. 8, 2014, granted, now 9,717,557, issued on Aug. 1, 2017.
Claims priority of provisional application 62/154,978, filed on Apr. 30, 2015.
Claims priority of provisional application 62/150,207, filed on Apr. 20, 2015.
Claims priority of provisional application 62/149,438, filed on Apr. 17, 2015.
Claims priority of provisional application 62/142,398, filed on Apr. 2, 2015.
Claims priority of provisional application 62/127,651, filed on Mar. 3, 2015.
Claims priority of provisional application 62/043,357, filed on Aug. 28, 2014.
Claims priority of provisional application 62/025,378, filed on Jul. 16, 2014.
Claims priority of provisional application 62/016,585, filed on Jun. 24, 2014.
Claims priority of provisional application 61/947,950, filed on Mar. 4, 2014.
Claims priority of provisional application 61/945,005, filed on Feb. 26, 2014.
Claims priority of provisional application 61/939,185, filed on Feb. 12, 2014.
Claims priority of provisional application 61/934,640, filed on Jan. 31, 2014.
Claims priority of provisional application 61/934,647, filed on Jan. 31, 2014.
Claims priority of provisional application 61/895,880, filed on Oct. 25, 2013.
Claims priority of provisional application 61/864,335, filed on Aug. 9, 2013.
Claims priority of provisional application 61/829,985, filed on May 31, 2013.
Claims priority of provisional application 61/821,014, filed on May 8, 2013.
Claims priority of provisional application 61/821,001, filed on May 8, 2013.
Claims priority of provisional application 61/820,992, filed on May 8, 2013.
Claims priority of provisional application 61/809,629, filed on Apr. 8, 2013.
Claims priority of provisional application 61/809,646, filed on Apr. 8, 2013.
Claims priority of provisional application 61/809,636, filed on Apr. 8, 2013.
Prior Publication US 2019/0038350 A1, Feb. 7, 2019
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 18/14 (2006.01); A61B 8/12 (2006.01); A61B 8/00 (2006.01); A61B 1/00 (2006.01); A61B 1/05 (2006.01); A61B 1/06 (2006.01); A61B 1/313 (2006.01); A61M 25/10 (2013.01); A61B 18/00 (2006.01); A61B 5/00 (2006.01); A61N 1/05 (2006.01); A61B 5/01 (2006.01); A61B 5/0538 (2021.01); A61B 18/12 (2006.01); A61B 18/18 (2006.01); A61M 25/01 (2006.01); A61M 25/04 (2006.01); A61B 17/00 (2006.01); A61B 17/22 (2006.01); A61M 25/06 (2006.01); A61B 90/00 (2016.01); A61B 90/30 (2016.01)
CPC A61B 18/1492 (2013.01) [A61B 1/00082 (2013.01); A61B 1/00096 (2013.01); A61B 1/05 (2013.01); A61B 1/0676 (2013.01); A61B 1/313 (2013.01); A61B 8/12 (2013.01); A61B 8/445 (2013.01); A61B 8/4494 (2013.01); A61M 25/10 (2013.01); A61M 25/1011 (2013.01); A61B 5/01 (2013.01); A61B 5/0538 (2013.01); A61B 5/6853 (2013.01); A61B 5/6858 (2013.01); A61B 18/1206 (2013.01); A61B 18/1815 (2013.01); A61B 90/30 (2016.02); A61B 90/361 (2016.02); A61B 90/37 (2016.02); A61B 2017/003 (2013.01); A61B 2017/0011 (2013.01); A61B 2017/00106 (2013.01); A61B 2017/00867 (2013.01); A61B 2017/22038 (2013.01); A61B 2018/00011 (2013.01); A61B 2018/0016 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00023 (2013.01); A61B 2018/00029 (2013.01); A61B 2018/00083 (2013.01); A61B 2018/0088 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00232 (2013.01); A61B 2018/00238 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00285 (2013.01); A61B 2018/00291 (2013.01); A61B 2018/00351 (2013.01); A61B 2018/00357 (2013.01); A61B 2018/00375 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00613 (2013.01); A61B 2018/00642 (2013.01); A61B 2018/00702 (2013.01); A61B 2018/00744 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/00797 (2013.01); A61B 2018/00815 (2013.01); A61B 2018/00839 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/00898 (2013.01); A61B 2018/00982 (2013.01); A61B 2018/124 (2013.01); A61B 2018/1465 (2013.01); A61B 2090/0454 (2016.02); A61B 2090/064 (2016.02); A61B 2090/065 (2016.02); A61B 2090/309 (2016.02); A61B 2090/364 (2016.02); A61B 2090/3614 (2016.02); A61B 2090/371 (2016.02); A61B 2090/373 (2016.02); A61B 2090/3784 (2016.02); A61B 2090/3937 (2016.02); A61B 2090/3966 (2016.02); A61B 2217/007 (2013.01); A61B 2218/002 (2013.01); A61B 2562/125 (2013.01); A61B 2562/164 (2013.01); A61M 25/0108 (2013.01); A61M 25/0133 (2013.01); A61M 25/0147 (2013.01); A61M 25/04 (2013.01); A61M 2025/0681 (2013.01); A61N 1/05 (2013.01); C08L 2201/12 (2013.01)] 14 Claims
OG exemplary drawing
 
1. An ablation catheter, comprising:
an elongate shaft;
an inflatable balloon positioned at a distal region of the elongate shaft;
a first ablation electrode disposed outside of and carried by an outer surface of the inflatable balloon;
a first ultrasound transducer disposed outside of the inflatable balloon and configured to monitor a characteristic associated with an ablation process; and
a flexible circuit, including a substrate layer, a first conductor and a second conductor, the flexible circuit disposed outside of and carried by the outer surface of the inflatable balloon, the first conductor in electrical communication with the first ablation electrode, and the second conductor in electrical communication with the first ultrasound transducer,
wherein the first ablation electrode is disposed over the substrate layer, and wherein the first ultrasound transducer is disposed on the substrate layer and is encapsulated by the first ablation electrode.